Literature DB >> 33912284

Nitroglycerin patch use in digital ischemia secondary to sepsis: a case report.

Devendrasing Vijaysing Jadhav1, Derek Mendonca2, Suresh Kotinatot1, Shiva Shankar1, Munira Al Mazmi1.   

Abstract

Sepsis results in intense disturbances in homoeostasis and is responsible for considerable morbidity and mortality in early infancy. Owing to insufficiency on part of infant to develop adequate inflammatory response to localize the infection, they usually progress to disseminated systemic infection, pneumonia and/or meningitis. We present the case of a 26 weeks preterm boy with acute digital ischemia in right index finger progressing to impending gangrene as a manifestation of septicemia. Use of topical nitroglycerin patch with meticulous monitoring successfully alleviated the impending peripheral gangrene without any adverse effects. Copyright: Devendrasing Vijaysing Jadhav et al.

Entities:  

Keywords:  Septicemia; case report; gangrene; ischemia; nitroglycerin patch

Year:  2021        PMID: 33912284      PMCID: PMC8051252          DOI: 10.11604/pamj.2021.38.114.27279

Source DB:  PubMed          Journal:  Pan Afr Med J


  9 in total

1.  Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates.

Authors:  A F Wong; L M McCulloch; A Sola
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

2.  High-dose tissue plasminogen activator, topical nitroglycerin, and heparin for severe ischemic injury in a neonate.

Authors:  Olugbenga Akingbola; Dinesh Singh; Rodney Steiner; Edwin Frieberg; Matei Petrescu
Journal:  Clin Pediatr (Phila)       Date:  2011-10-12       Impact factor: 1.168

3.  Topical use of nitroglycerin ointment in neonates.

Authors:  P van Reempts; B Van Overmeire
Journal:  J Pediatr       Date:  1990-01       Impact factor: 4.406

4.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 5.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

6.  Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors.

Authors:  M-H Tsai; S-M Chu; C-W Lee; J-F Hsu; H-R Huang; M-C Chiang; R-H Fu; R Lien; Y-C Huang
Journal:  Clin Microbiol Infect       Date:  2014-06-14       Impact factor: 8.067

Review 7.  Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.

Authors:  M G Bogaert
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 8.  Unfractionated heparin therapy in infants and children.

Authors:  Fiona Newall; Linda Johnston; Vera Ignjatovic; Paul Monagle
Journal:  Pediatrics       Date:  2009-02-16       Impact factor: 7.124

9.  Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Shih-Ming Chu; Reyin Lien; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Chiang-Wen Lee; Yhu-Chering Huang
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.